Recent Quotes (30 days)

You have no recent quotes
chg | %

Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 240   

Articles published

PFE 35.51 -0.45 (-1.25%)
price chart
Pfizer Spins Off New Firm for Some Rare Disease Drugs
Pfizer Inc. will spin off four experimental drugs that it had decided to shelve into a new company, called SpringWorks Therapeutics, to give them a better chance to get developed with the backing of outside investors including Bain Capital.
In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding  Forbes
Pfizer tests new way to trial more drugs  Financial Times
Pfizer's Ibrance To Rally Share Price Past $40
Shares of Pfizer Inc. (NYSE:PFE) are finally starting to catch a bid which is encouraging. Shares have been pretty much range bound for the past 24 months or so but finally broke through $36 a share last week which looks significant.
Pfizer files suit against J&J over Remicade contracts
(Reuters) - Drugmaker Pfizer Inc (PFE.N) on Wednesday filed a lawsuit against Johnson & Johnson (JNJ.N), saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of ...
Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of ...  Wall Street Journal (subscription)
Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb
Pfizer's pipeline includes 10 programs awaiting regulatory approval and 32 late-stage programs. The company also has another 17 phase 2 programs.
Recent Buy: Pfizer Inc.
I will be explaining my fourth buy of the month of August. Share prices of Pfizer Inc. (PFE) have been hovering between $29.00 and $36.00 for the past two and half years.
Pfizer, Inc. (NYSE:PFE) Stake Decreased by WINTON GROUP Ltd  The Ledger Gazette
Pfizer Inc. (PFE) Moves Higher on Volume Spike for September 14
Global Insomnia Market Key Companies: Eisai, Pfizer Inc, Merck , Sanofi ...
The Insomnia industry report also provides details information key players like Eisai Co, Pfizer Inc, Merck & Co Inc, Sanofi Pasteur, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc, Pernix Therapeutics, Purdue Pharma LP, Consumer ...
Pfizer Inc. (PFE) Closes 1.25% Down on the Day for September 25
Shares of Pfizer Inc. (PFE) ended the trading day Monday at $35.51, representing a move of -1.25%, or $0.45 per share, on volume of 21.83 million shares.
Investment Centers of America Inc. Sells 27785 Shares of Pfizer, Inc. (PFE)  The Ledger Gazette
Pfizer, Astellas prostate cancer drug promising in late-stage trial
(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.
UPDATE 1-Pfizer, Astellas prostate cancer drug clears late-stage trial  Business Insider
Pfizer Inc.: – Pfizer and Astellas Announce Positive Top-Line Results from ...  The Wall Street Transcript
Which Way Traders Signposts Pfizer Inc. (PFE), Oracle Corporation (ORCL) Stocks?
ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.
Does These Stocks Deserve Your Investment Dollars? – Pfizer Inc. (PFE ...  USA Commerce Daily
FDA sends damning warning letter to Pfizer after misfiring EpiPens linked to ...
The US Food and Drug Administration has sent a damning warning letter to drug giant Pfizer Inc (NYSE:PFE) after it received “hundreds of complaints” that the anti-allergy EpiPen device misfired “during life-threatening emergencies”.
FDA Warns Pfizer's Meridian Unit on EpiPen Oversight, Quality Issues  Wall Street Journal (subscription)
EpiPen Maker Neglected 'Hundreds' of Complaints About Defects  Bloomberg